Diagnostic Approach for Dementia in Older Adults

Introduction to Diagnostic Steps

• The American Academy of Neurology recommends diagnosing dementia through a structured clinical evaluation that includes corroborative informant history using validated tools, objective cognitive testing with standardized instruments, functional assessment to confirm interference with daily activities, targeted laboratory testing to exclude reversible causes, and brain MRI to identify structural pathology 1, 2, 5.

Step 1: Obtain Corroborative Informant History

• The Alzheimer's Association suggests obtaining history from a reliable informant using structured validated tools such as the AD8, IQCODE, or Alzheimer's Questionnaire to assess changes in cognition, function, and behavior 1, 2, 5.

Step 2: Perform Objective Cognitive Testing

• The American Geriatrics Society recommends administering the Montreal Cognitive Assessment (MoCA) for suspected mild dementia or the Mini-Mental State Examination (MMSE) for moderate dementia, with a cut point of 23/24 or 24/25 for most primary care populations 6, 7.

Step 3: Assess Functional Status

• The American Academy of Family Physicians suggests evaluating impact on instrumental activities of daily living (IADLs) using structured tools like the Pfeffer Functional Activities Questionnaire (FAQ), Disability Assessment for Dementia (DAD), Lawton IADL Scale, or ECog 3, 4.

Step 4: Core Laboratory Testing

• The American College of Physicians recommends obtaining the following tests to exclude reversible causes of cognitive impairment: complete blood count (CBC), comprehensive metabolic panel, thyroid-stimulating hormone (TSH) and free T4, vitamin B12 and folate levels, liver function tests, and HIV testing if risk factors are present 3, 4.

Step 5: Structural Neuroimaging

• The Radiological Society of North America suggests that brain MRI without contrast is strongly recommended over CT, particularly for detecting vascular lesions, white matter disease, medial temporal lobe atrophy, tumors, hydrocephalus, and hemorrhages 5.

Step 6: Physical and Neurological Examination

• The Mayo Clinic recommends performing a comprehensive physical examination with specific attention to findings suggesting underlying medical contributors, and conducting a dementia-focused neurological examination assessing focal neurologic abnormalities, gait speed and motor movements, reflexes and Babinski signs, and extrapyramidal signs 8.

Step 7: Assess for Common Contributors and Comorbidities

• The American Heart Association suggests systematically evaluating for conditions that can exacerbate or mimic dementia, including sensory deficits, sleep disorders, medications, metabolic disturbances, mood disorders, pain, and vascular risk factors 1, 3, 4, 7, 8.

Step 8: Synthesize Diagnostic Formulation

• The National Institute on Aging recommends integrating information about risk profile, history of symptoms, and examination findings to determine whether cognitive-behavioral syndrome is present, the severity level, and the most likely etiology 5, 8.

Step 9: Consider Biomarkers in Atypical Cases

• The National Institute of Neurological Disorders and Stroke suggests considering biomarkers such as cerebrospinal fluid assays for amyloid beta and tau proteins, amyloid PET or tau PET imaging, and genetic testing for familial forms in atypical presentations 1, 2, 5.

Step 10: Establish Follow-Up and Monitoring Plan

• The Alzheimer's Association recommends scheduling follow-up visits every 6-12 months with serial cognitive assessments to document progression and monitor treatment response, and using a multi-dimensional approach assessing cognition, functional autonomy, behavioral symptoms, and caregiver burden 3, 4.